25-05-2025
Jefferies Reaffirms Their Buy Rating on Mankind Pharma Ltd. (MANKIND)
Jefferies analyst Alok Dalal maintained a Buy rating on Mankind Pharma Ltd. (MANKIND – Research Report) on May 23 and set a price target of INR2,870.00. The company's shares closed last Friday at INR2,425.00.
Confident Investing Starts Here:
According to TipRanks, Dalal is ranked #4967 out of 9536 analysts.
In addition to Jefferies, Mankind Pharma Ltd. also received a Buy from J.P. Morgan's Bansi Desai in a report issued on May 21. However, on the same day, Bank of America Securities maintained a Sell rating on Mankind Pharma Ltd. (NSE: MANKIND).
